● Recruiting

Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Condition: Partial Lipodystrophy · Sponsor: Amryt Pharma

PhasePhase 4

Planned participants12

Who can joinAll sexes, 12 Years to no upper limit

Healthy volunteersNo

About this study

This is an Open Label, Phase IV, Post Authorisation Study to Evaluate the Efficacy, Safety and Immunogenicity of Daily Subcutaneous Metreleptin Treatment in people with Partial Lipodystrophy

This description comes directly from the study's public registry record.

Talk to the study team

Janet Boylan · +3905212791 · clinicaltrials_info@chiesi.com

Always discuss trial participation with your own doctor first.

Locations (12)

Centre Hospitalier Régional Universitaire de Lille (CHRU) - Hôpital Claude Huriez	Lille, France	Recruiting
Hopital Pitie-Salpetriere	Paris, France	Recruiting
Hôpital Saint-Antoine	Paris, France	Recruiting
Centre Hospitalier Lyon-Sud	Pierre-Bénite, France	Recruiting
Charite-Universitaetsmedizin Berlin - Campus Charite Mitte (CCM)	Berlin, Germany	Recruiting
Universitaetsklinikum Ulm - Klinik fuer Kinder- und Jugendmedizin	Ulm, Germany	Not Yet Recruiting
Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi	Bologna, Italy	Recruiting
Universitá degli Studi "Magna Graecia" di Catanzaro	Catanzaro, Italy	Not Yet Recruiting
Azienda Ospedaliero Universitaria Maggiore della Carità di Novara	Novara, Italy	Recruiting
Azienda Ospedaliero Universitaria Pisana - Stabilimento di Cisanello	Pisa, Italy	Recruiting
A.S.U Integrata di Udine - Presidio Ospedaliero Santa Maria della Misericordia	Udine, Italy	Recruiting
Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital	Cambridge, United Kingdom	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06484868